GL1X · GenesisL1 explorer

Research workbench

Crystal structure of jacalin-T-antigen complex

Analyse Crystal structure of jacalin-T-antigen complex in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1M26
Type
protein
Length
594 residues
Chains
8
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Jacalin, alpha chain; Jacalin, beta chain
Ligands
A2G, GAL
Pockets
4 · best druggability 0.81

Structure

x-ray diffraction · 3 distinct chains · 0% helix, 62% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, C, E, GJacalin, alpha chainprotein1330% helix, 67% strand—
B, F, HJacalin, beta chainprotein150% helix, 47% strand—
DJacalin, beta chainprotein170% helix, 41% strand—

Ligands and binding sites

  • A2G · 2-acetamido-2-deoxy-alpha-D-galactopyranose · sugar · 4 copies · chains A, C, E, G
  • GAL · beta-D-galactopyranose · sugar · 4 copies · chains A, C, D, E, F, G

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15770.810.8783empty
22420.500.7538empty
31470.390.7328empty
4600.290.7416empty

Interfaces

22 interfaces between chains.

  • C–D · 559 Ų buried · 7 hydrogen bonds · protein-protein
  • A–B · 540 Ų buried · 8 hydrogen bonds · protein-protein
  • G–H · 534 Ų buried · 8 hydrogen bonds · protein-protein
  • E–F · 528 Ų buried · 7 hydrogen bonds · protein-protein
  • B–C · 464 Ų buried · 10 hydrogen bonds · protein-protein

Compared structures

  • 1M26 · Crystal structure of jacalin-T-antigen complex · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.